Litigation Details for Astellas US LLC v. Accord Healthcare, Inc. (D. Del. 2019)
✉ Email this page to a colleague
Astellas US LLC v. Accord Healthcare, Inc. (D. Del. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-06-25 |
| Court | District Court, D. Delaware | Date Terminated | 2021-08-18 |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | |
| Patents | 8,106,183; 9,085,601 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Astellas US LLC v. Accord Healthcare, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Astellas US LLC v. Accord Healthcare, Inc. (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-06-25 | 1 | Complaint | polymorphs.” The ’301 patent is a reissue of U.S. Patent No. 9,085,601 (the “’601 patent”), which issued …8,524,883 (the “’883 patent”). The ’183 patent, ’301 patent, and ’883 patent are collectively referred to herein…expiration of U.S. Patent Nos. 8,106,183 (the “’183 patent”), RE 47,301 (the “’301 patent”), and 8,524,883…by the process patented by the ’883 patent, prior to the expiration of the ’883 patent. 30. …. This is an action for patent infringement arising under the patent laws of the United States, | External link to document |
| 2019-08-21 | 13 | SO ORDERED | drug product prior to expiration of U.S. Patent Nos. 8,106,183, RE 47,301, and 8,524,883. IT… C.A. No. 18-1675-CFC, which involves the same patents and relates to Defendants' efforts to market…2019 18 August 2021 1:19-cv-01199 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2019-06-25 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,106,183 ;US RE 47,301 E ;…2019 18 August 2021 1:19-cv-01199 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2019-07-16 | 7 | Answer to Complaint | of U.S. Patent Nos. 8,106,183 (the “’183 patent”), RE 47,301 (the “’301 patent”), and 8,524,883…,883 (the “’883 patent”). The ’183 patent, ’301 patent, and ’883 patent are collectively… The ’301 patent is a reissue of U.S. Patent No. 9,085,601 (the “’601 patent”), which issued…process patented by the ’883 patent, prior to the expiration of the ’883 patent. RESPONSE…. This is an action for patent infringement arising under the patent laws of the United | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
